Physician profile
Muhammad Nagy
NPI 1043773864
$7,047.73
in general payments reported to CMS, 2019-2025
11 companies · $1,128 in 2025
The $1,128 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $159 · 2024: $5,761 · 2025: $1,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,308 · Food and Beverage: $1,736 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,307.83 |
| Food and Beverage | $1,736.05 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,811.95 | 2024 | Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device, Trufill, Cerepak Uniform |
| Penumbra, INC. | $1,647.69 | 2024 | Penumbra System, Indigo System |
| Medtronic, INC. | $1,078.99 | 2025 | Pipeline, Onyx 18 |
| Stryker Corporation | $934.05 | 2024 | Evolve |
| Abbott Laboratories | $645.43 | 2024 | Xact |
| Microvention, INC. | $410.66 | 2024 | Web Aneurysm Embolization System, Stent |
| Route 92 Medical, INC. | $289.99 | 2024-2025 | 8f Base Camp Sheath System |
| Abbvie INC. | $139.06 | 2023-2025 | |
| Ucb, INC. | $37.12 | 2023 | Briviact |
| Celgene Corporation | $29.09 | 2023 | Zeposia |
| Cardiva Medical, INC. | $23.70 | 2024 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Nagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.